Mirna Therapeutics
OTC: SYBXAustin, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MW
Matthew WinklerDirector
MP
Michael PowellDirector
CS
Clay SiegallDirector
SK
Sinil KimExecutive Officer
PL
Paul LammersExecutive Officer, Director
JI
Jon IrvinExecutive Officer
LA
Larry AllevaDirector
CG
Corey GoodmanDirector
CD
Casi DeYoungExecutive Officer
EM
Ed MathersDirector
EJ
Elaine JonesDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$80MraisedJun 2019 · 1 investors · BiotechnologyRule 506(b)
▶$80MraisedJun 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward MathersDirector
- Chau KhuongDirector
- Patricia HurterDirector
- Peter BarrettDirector
- Michael PowellDirector
- Aoife BrennanExecutive Officer, Director
- Nick LeschlyDirector
- Richard P. SheaDirector
- Todd ShegogExecutive Officer
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.8MraisedMay 2015 · 24 investors · PharmaceuticalsRule 506(b)
▶$41.8MraisedMay 2015 · 24 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WinklerDirector
- Michael PowellDirector
- Clay SiegallDirector
- Sinil KimExecutive Officer
- Paul LammersExecutive Officer, Director
- Jon IrvinExecutive Officer
- Larry AllevaDirector
- Corey GoodmanDirector
- Casi DeYoungExecutive Officer
- Ed MathersDirector
- Elaine JonesDirector
- Offering amount
- $45M
- Amount sold
- $41.8M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.